Results 51 to 60 of about 34,408 (308)

Removal of a retroperitoneal foreign body by laparoscopic surgery

Gynecology and Minimally Invasive Therapy, 2019
Migration of intrauterine devices (IUDs) into the abdominal cavity is rare. In this report, we describe a patient in whom a levonorgestrel intrauterine system (LNG-IUS) device was initially misplaced outside of the uterus, likely due to stenosis of the ...
Saeki Shinichiro, Yu Wakimoto, Hidetake Kamei, Atsushi Fukui, Hiroaki Shibahara   +4 more
doaj   +1 more source

Clinically Used Hormone Formulations Differentially Impact Memory, Anxiety-Like, and Depressive-Like Behaviors in a Rat Model of Transitional Menopause

Frontiers in Behavioral Neuroscience, 2021
A variety of U.S. Food and Drug Administration-approved hormone therapy options are currently used to successfully alleviate unwanted symptoms associated with the changing endogenous hormonal milieu that occurs in midlife with menopause. Depending on the
Stephanie V. Koebele, Stephanie V. Koebele, Ryoko Hiroi, Ryoko Hiroi, Zachary M. T. Plumley, Zachary M. T. Plumley, Ryan Melikian, Ryan Melikian, Alesia V. Prakapenka, Alesia V. Prakapenka, Shruti Patel, Shruti Patel, Catherine Carson, Catherine Carson, Destiney Kirby, Destiney Kirby, Sarah E. Mennenga, Sarah E. Mennenga, Loretta P. Mayer, Cheryl A. Dyer, Heather A. Bimonte-Nelson, Heather A. Bimonte-Nelson   +21 more
doaj   +1 more source

The role of levonorgestrel intra‐uterine system in the management of adenomyosis: A systematic review and meta‐analysis of prospective studies

Acta Obstetricia et Gynecologica Scandinavica, 2019
The levonorgestrel intrauterine system (LNG‐IUS) is a long‐acting hormone‐releasing uterine device that has many non‐contraceptive benefits. The study aims to assess the safety and efficacy of LNG‐IUS in the management of adenomyosis.
A. M. Abbas, A. Samy, K. Atwa, H. Ghoneim, Mariam Lotfy, Heba Saber, Asmaa M. Abdellah, Amira M. El Bahie, Ahmed A. Aboelroose, Asmaa M. El Gedawy, Mona Mostafa, M. Elsenity, M. Samy, S. Safwat, R. Abdelrahman, A. S. Salah El Din, E. Badran, A. M. Abdelkader, Ameer A AbdAllah   +18 more
semanticscholar   +1 more source

Implantable Microarray Patch: Engineering at the Nano and Macro Scale for Sustained Therapeutic Release via Synthetic Biodegradable Polymers

Advanced Materials Technologies, Volume 10, Issue 6, March 18, 2025.
This review focuses on the application of synthetic biodegradable microarray patches (MAPs) in sustained drug delivery. Compared to conventional MAPs which release drugs into the skin in an immediate manner, these implantable MAPs release drugs into skin microcirculation gradually as the biodegradable polymers degrade, thus offering sustained release ...
Li Zhao, Akmal Hidayat Bin Sabri, Mary B. McGuckin, Linlin Li, Zihao Wang, Eneko Larrañeta, Ryan F. Donnelly   +6 more
wiley   +1 more source

Hormonal contraceptive methods and risk of HIV acquisition in women : a systematic review of epidemiological evidence [PDF]

, 2014
Peer reviewedPublisher ...
Curtis, Kathryn M., Hannaford, Philip, Phillips, Sharon J., Polis, Chelsea B., Raymond, Elizabeth, Steyn, Petrus S., Turner, Abigail Norris, Westreich, Daniel J.   +7 more
core   +2 more sources

Drug–drug interaction profile of ritlecitinib as perpetrator and victim through cytochrome P450

British Journal of Clinical Pharmacology, EarlyView.
Aims To assess the effect of a potent cytochrome P450 (CYP) 3A inhibitor and CYP inducer on the pharmacokinetics of ritlecitinib, a JAK3/TEC family kinase inhibitor, and assess the effect of ritlecitinib on the pharmacokinetics of CYP substrates (midazolam, efavirenz, tolbutamide, caffeine and oral contraceptives [ethinyl oestradiol and levonorgestrel])
Vivek S. Purohit, Yeamin Huh, Martin E. Dowty, Anna Plotka, Alexandre Lejeune, Hindu Kalluru, Brian Hee   +6 more
wiley   +1 more source

Levonorgestrel-Releasing Intrauterine Device

Annals of Medicine, 1990
An intrauterine contraceptive device releasing 20 micrograms levonorgestrel daily has been studied for 15 years. The international clinical experience covers over 8000 woman years. Main characteristics of the levonorgestrel-releasing intrauterine device are its great effectiveness in preventing unplanned pregnancies and a reduction in menstrual ...
Tapani Luukkainen, Pekka Lähteenmäki, Juhani Toivonen   +2 more
openaire   +3 more sources

PREVALENCE AND PATTERN OF UTERINE BLEEDING AMONG BREASTFEEDING WOMEN USING PROGESTERONE-ONLY PILLS

Public Health of Indonesia, 2018
Background: Progesterone-Only Pill (POPs) is one of the ideal oral contraceptive methods for breastfeeding women. Discontinuation of POPs was mostly due to bleeding pattern disorders.
Prima Dhewi Ratrikaningtyas, Dian Rosdiana, Siswanto Agus Wilopo   +2 more
doaj   +1 more source

Primary dysmenorrhea: strategy and tactics of treatment [PDF]

Гинекология, 2018
The article summarizes the results of numerous randomized studies and structured the approach to the tactics of managing patients with primary dysmenorrhea.
Yu E Dobrokhotova, E I Borovkova, S A Zalesskaia   +2 more
doaj   +1 more source

Levonorgestrel as a Potential Trigger of Acute Bilateral Central Serous Chorioretinopathy: Case Report

Case Reports in Ophthalmology, 2023
This is a first ever report describing a case of acute bilateral central serous chorioretinopathy which developed shortly after the consumption of levonorgestrel as emergency contraception. A 27-year-old female patient visited the emergency department of
Vedran Nemet
doaj   +1 more source